US Stock MarketDetailed Quotes

GNLX Genelux

Watchlist
  • 3.960
  • +0.600+17.86%
Close Jan 24 16:00 ET
  • 4.070
  • +0.110+2.78%
Post 20:01 ET
136.77MMarket Cap-4.94P/E (TTM)

About Genelux Company

Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.

Company Profile

SymbolGNLX
Company NameGenelux
Listing DateJan 26, 2023
Issue Price6.00
Founded2001
CEOMr. Thomas Zindrick, J.D.
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address2625 Townsgate Road,Suite 230
CityWestlake Village
ProvinceCalifornia
CountryUnited States of America
Zip Code91361
Phone1-858-267-9889
Websitehttp://www.genelux.com

Company Executives

  • Name
  • Position
  • Salary
  • Thomas Zindrick, J.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 6.20M
  • Dr. Paul Scigalla, M.D.,PhD
  • Chief Medical Officer
  • --
  • Lourie S. Zak
  • Chief Financial Officer and Principal Accounting Officer
  • 2.83M
  • Dr. Joseph Cappello, PhD
  • Chief Technical Officer
  • --
  • Dr. Tony Yu, PhD
  • Senior Vice President, Clinical Development
  • --
  • Dr. John Thomas, PhD
  • Independent Director
  • 278.13K
  • John W. Smither
  • Independent Director
  • 328.62K
  • Mary Mirabelli
  • Independent Director
  • 222.07K
  • James L. Tyree
  • Lead Independent Director
  • 284.13K
  • Sean Ryder, J.D.
  • General Counsel and Corporate Secretary
  • --
  • Ralph Smalling
  • Head, Regulatory
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
January rate meeting coming! Fed's pause in rate cuts a foregone conclusion?
🎙️Discussion 1. Will the Fed press the "pause button" on rate cuts as expected? 2. Do you think President Trump's political actions will ch Show More
Here's the Breakdown for December CPI, in One Chart
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.